Activating two somatostatin receptors enhances amyloid beta breakdown and improves memory in models of Alzheimer’s disease.
Researchers for over thirty years have been trying to unravel the mystery of how a key biological molecule self assembles into a rogue protein-like substance—amyloid—which is thought to play a role in ...
A study shows people with the worst memory problems also had the most leakage in their brain's blood vessels -- regardless of whether abnormal proteins amyloid and tau were present. Leaky capillaries ...
IFLScience on MSN
Experimental Alzheimer’s drug could have the power to halt disease before symptoms even start
A breakthrough new Alzheimer’s disease treatment is stopping neurodegeneration in its tracks, even before symptoms appear.
The new understanding of molecular events that drive the various forms of amyloidosis has led to the expansion of therapeutic options to prevent end-stage disease or even offer a cure, which has added ...
People who carry the APOE4 genetic variant face a substantial risk for developing Alzheimer's disease. Now, researchers have identified a compound that targets the APOE protein in the brains of mice ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback